Cargando…
Evolución clínica de 31 pacientes adultos con trombocitopenia inmune tratados con rituximab
BACKGROUND: Primary immune thrombocytopenia (ITP) is an autoimmune disease that could cause different grades of bleeding, which could even threat the patients’ life or make them experience poor quality of life. ITP can be treated with rituximab either as a first or second-line therapy option, result...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Instituto Mexicano del Seguro Social
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395956/ https://www.ncbi.nlm.nih.gov/pubmed/36542424 |